American Society of Nephrology and Renalytix to Co-Host Virtual Capital Markets Day for Kidney Health

NASDAQ Market News

NEXT STORY
Crinetics Pharmaceuticals Lead ACTH Antagonist for Congenital Adrenal Hyperplasia and Cushing’s Disease (CRN04894) Advances into Phase 1 Study
PREV STORY
SpringWorks Therapeutics to Present at the Guggenheim Healthcare Talks 2021 Oncology Day
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Junshi Biosciences and Coherus Announce Completion of Rolling BLA Submission to U.S. FDA for Toripalimab for the Treatment of Nasopharyngeal Carcinoma

author_avatar
NASDAQ Market News

Dante Labs acquires Cambridge Cancer Genomics to create global excellence in precision oncology

author_avatar
NASDAQ Market News

Calithera Biosciences Reports CB-839 Phase I Triple Negative Breast Cancer Combination Data at the 2016 San Antonio Breast Cancer Symposium

SOUTH SAN FRANCISCO, Calif., Dec. 06, 2016 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), ...

author_avatar
NASDAQ Market News